FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

109083009: Metformin hydrochloride (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
173618010 Metformin hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
608005017 Metformin hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
173618010 Metformin hydrochloride en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
173618010 Metformin hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
608005017 Metformin hydrochloride (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
608005017 Metformin hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
6501000188115 metformine chlorhydrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
824331000172119 chlorhydrate de metformine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
6501000188115 metformine chlorhydrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
824331000172119 chlorhydrate de metformine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Metformin hydrochloride Is a Product containing metformin (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride Is a Metformin (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride Is modification of (attribute) Metformin (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride Is a Biguanide oral hypoglycemic agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing metformin hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride 850 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride 1 g oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride 500mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing glibenclamide and metformin hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glibenclamide 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glibenclamide 5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride 100 mg/mL oral solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride 750mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing glipizide and metformin hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Glipizide 2.5 mg and metformin hydrochloride 250 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glipizide 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Glipizide 5 mg and metformin hydrochloride 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride 625 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Glucophage 625mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride 1g m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 500 milligram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 2 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride 500 mg and repaglinide 1 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride 500 mg and repaglinide 2 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride 850 mg and pioglitazone (as pioglitazone hydrochloride) 15 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 500 milligram and pioglitazone hydrochloride 15 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride 500 mg and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride 1 g and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each prolonged-release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride + saxagliptin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 850 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 850 mg oral tablet Has basis of strength substance (attribute) True Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 1 g oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 1 g oral tablet Has basis of strength substance (attribute) True Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 625 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 625 mg oral tablet Has basis of strength substance (attribute) True Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 500 mg and repaglinide 2 mg oral tablet Has basis of strength substance (attribute) False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Metformin hydrochloride 500 mg and repaglinide 1 mg oral tablet Has basis of strength substance (attribute) False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 2 mg oral tablet Has basis of strength substance (attribute) False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 500 milligram and pioglitazone hydrochloride 15 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 500 milligram and pioglitazone hydrochloride 15 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 850 mg and pioglitazone (as pioglitazone hydrochloride) 15 mg oral tablet Has basis of strength substance (attribute) False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 500 milligram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 500 milligram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 500 mg and repaglinide 2 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 500 mg and repaglinide 2 mg oral tablet Has basis of strength substance (attribute) True Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 500 mg and repaglinide 1 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 500 mg and repaglinide 1 mg oral tablet Has basis of strength substance (attribute) True Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 2 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 2 mg oral tablet Has basis of strength substance (attribute) True Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glibenclamide 5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glibenclamide 5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glipizide 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glipizide 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Glipizide 5 mg and metformin hydrochloride 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Glipizide 5 mg and metformin hydrochloride 500 mg oral tablet Has basis of strength substance (attribute) False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Metformin hydrochloride 850 mg and pioglitazone (as pioglitazone hydrochloride) 15 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 850 mg and pioglitazone (as pioglitazone hydrochloride) 15 mg oral tablet Has basis of strength substance (attribute) True Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glibenclamide 5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glibenclamide 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glibenclamide 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Glipizide 5 mg and metformin hydrochloride 500 mg oral tablet Has basis of strength substance (attribute) True Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Glipizide 2.5 mg and metformin hydrochloride 250 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Glipizide 2.5 mg and metformin hydrochloride 250 mg oral tablet Has basis of strength substance (attribute) False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Metformin hydrochloride 750 mg prolonged-release oral tablet Has basis of strength substance (attribute) True Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 750 mg prolonged-release oral tablet Has precise active ingredient True Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug) Has basis of strength substance (attribute) True Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug) Has precise active ingredient True Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 1 g prolonged-release oral tablet Has precise active ingredient True Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 1 g prolonged-release oral tablet Has basis of strength substance (attribute) True Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glibenclamide 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glibenclamide 5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Metformin hydrochloride 1 g oral tablet Has precise active ingredient True Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 850 mg oral tablet Has precise active ingredient True Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Glipizide 2.5 mg and metformin hydrochloride 250 mg oral tablet Has precise active ingredient False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Metformin hydrochloride 500 mg and repaglinide 2 mg oral tablet Has precise active ingredient False Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Metformin hydrochloride 625 mg oral tablet Has precise active ingredient True Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Metformin hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1

Page 1 of 2 End

This concept is not in any reference sets

Back to Start